Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a…

Overview of attention for article published in Arthritis Research & Therapy, April 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 1 news outlet

twitter: 13 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 47 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Minimal impact of targeted therapy tapering on AE rates in RA, axSpA

medwireNews, 05 May 2020

05-05-2020 | Rheumatology | News | Article medwireNews: Tapering of biologic DMARDs or Janus kinase (JAK) inhibitors does not…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.